ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

AACR Supports Bypass Budget; Public Consortium Sequences Mouse Genome

May 10, 2002

FASEB Delivers Its Recommendations For Federal Research Funding in 2013

February 3, 2012

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

New Announcement For CREG On Radio-Chemotherapy Combines Study New Available

July 28, 1978

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007